OVID THERAPEUTICS DL-,001 earnings per share and revenue

1OT earnings per share for the last quarter are -0.16 EUR whereas the estimation was -0.21 EUR which accounts for 23.93% surprise. Company revenue for the same period amounts to 137.16 k EUR despite the estimated figure of 48.26 k EUR. Estimated earnings per share for the next quarter are -0.21 EUR, and revenue is expected to reach 56.69 k EUR. Also watch annual changes over time to get a bigger picture of 1OT earnings per share and revenue dynamics.